ARTICLE | Management Tracks
Toshinori Agatsuma, Daiichi’s head of research, passes away
Plus: Lange becomes CBO of Avidity and updates from CABS, BIO, Zevra and Achieve
December 10, 2024 1:18 AM UTC
Daiichi Sankyo Co. Ltd. (Tokyo:4568) announced the sudden passing of Executive Officer, Head of Research Toshinori Agatsuma, who led the team that invented the company’s antibody-drug conjugate (ADC) technology. .
“Dr. Agatsuma was a true scientific trailblazer who passionately believed that antibody-based therapies were the future of medicine, which sparked the transformation of Daiichi Sankyo into a global company with competitive advantage in oncology,” Executive Chairman and CEO Sunao Manabe said in a statement...